Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advair on Endothelial Function in COPD
NCT01209715Phase 2Withdrawn
- Sponsor
- University of Miami
- Start
- Oct 2010
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by University of Miami. Primary endpoint: Change in Airway Blood Flow at 3 weeks. Planned start Oct 2010; status: withdrawn.
02
Drugs
fluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01209715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01209715.